- Home
- DTIL vs NTRB Comparison
DTIL vs NTRB Comparison
Compare DTIL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- NTRB
- Stock Information
- Founded
- DTIL 2006
- NTRB 2016
- Country
- DTIL United States
- NTRB United States
- Employees
- DTIL N/A
- NTRB N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- DTIL Health Care
- NTRB Health Care
- Exchange
- DTIL Nasdaq
- NTRB Nasdaq
- Market Cap
- DTIL 44.1M
- NTRB 46.4M
- IPO Year
- DTIL 2019
- NTRB N/A
- Fundamental
- Price
- DTIL $4.96
- NTRB $4.11
- Analyst Decision
- DTIL Strong Buy
- NTRB
- Analyst Count
- DTIL 3
- NTRB 0
- Target Price
- DTIL $37.67
- NTRB N/A
- AVG Volume (30 Days)
- DTIL 1.3M
- NTRB 26.3K
- Earning Date
- DTIL 11-04-2024
- NTRB 12-04-2024
- Dividend Yield
- DTIL N/A
- NTRB N/A
- EPS Growth
- DTIL N/A
- NTRB N/A
- EPS
- DTIL 1.45
- NTRB N/A
- Revenue
- DTIL $75,096,000.00
- NTRB $2,021,771.00
- Revenue This Year
- DTIL $52.95
- NTRB N/A
- Revenue Next Year
- DTIL N/A
- NTRB N/A
- P/E Ratio
- DTIL $2.57
- NTRB N/A
- Revenue Growth
- DTIL 43.62
- NTRB N/A
- 52 Week Low
- DTIL $3.61
- NTRB $2.22
- 52 Week High
- DTIL $19.43
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- DTIL 46.54
- NTRB 44.78
- Support Level
- DTIL $5.10
- NTRB $3.90
- Resistance Level
- DTIL $7.44
- NTRB $5.16
- Average True Range (ATR)
- DTIL 0.66
- NTRB 0.33
- MACD
- DTIL 0.14
- NTRB -0.01
- Stochastic Oscillator
- DTIL 35.25
- NTRB 27.04
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.